A5064608762- Breast Cancer Treatment Studies
- Radiomics and Machine Learning in Medical Imaging
- Cancer Treatment and Pharmacology
- Breast Lesions and Carcinomas
- Breast Implant and Reconstruction
- HER2/EGFR in Cancer Research
- Advanced Breast Cancer Therapies
- AI in cancer detection
- Advances in Oncology and Radiotherapy
- Advanced Radiotherapy Techniques
- Medical Imaging Techniques and Applications
- Cancer Genomics and Diagnostics
- Management of metastatic bone disease
- Radiopharmaceutical Chemistry and Applications
- Nutrition and Health in Aging
- Brain Metastases and Treatment
- Frailty in Older Adults
- Head and Neck Cancer Studies
- Cancer Cells and Metastasis
- Colorectal Cancer Surgical Treatments
- Cancer survivorship and care
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
- Ancient Mediterranean Archaeology and History
- Biomedical Text Mining and Ontologies
Istituti di Ricovero e Cura a Carattere Scientifico
2019-2025
Agostino Gemelli University Polyclinic
2016-2025
Assuta Medical Center
2023
Advanced Radiation Therapy (United States)
2019-2020
Università Cattolica del Sacro Cuore
2012-2016
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
2009-2015
Hormone receptor-positive/HER2-negative breast cancer (BC) is the most common subtype of BC and typically occurs as an early, operable disease. In patients receiving neoadjuvant chemotherapy (NACT), pathological complete response (pCR) rare multiple efforts have been made to predict disease recurrence. We developed a framework pCR using clinicopathological characteristics widely available at diagnosis. The machine learning (ML) models were trained (n = 463), evaluated in internal validation...
How to cite this article: Valentini V., Marazzi F., Bossola M., Miccichè Nardone L., Balducci Dinapoli N., Bonomo P., Autorino R., Silipigni S., Giuliani Tamanti C., Mele M.C. & Martorana G.E. (2012) Nutritional counselling and oral nutritional supplements in head neck cancer patients undergoing chemoradiotherapy. J Hum Nutr Diet. 25 , 201–208 Abstract Background: The role of (NC) with or without (ONS) receiving chemoradiotherapy (CRT) for (HNC) still remains be clearly defined,...
Breast cancer is the most common tumor in women and represents leading cause of death. Radiation therapy plays a key-role treatment all breast stages. Therefore, adoption evidence-based treatments warranted, to ensure equity access standardization care clinical practice.This national document on highest available data was developed endorsed by Italian Association Clinical Oncology (AIRO) Cancer Group.We analyzed literature regarding radiation therapy, using SIGN (Scottish Intercollegiate...
Mesenchymal tumors of the breast represent a rare and diverse group neoplasms, accounting for 0.5% all tumors. These originate from mesenchymal tissues encompass variety histological subtypes. Malignant are particularly aggressive, characterized by high propensity local recurrence an overall poor prognosis. The rarity these cases has hindered development robust clinical studies, resulting in lack standardized diagnostic treatment guidelines considerable variability management. This review...
Magnetic resonance-guided radiotherapy (MRgRT) represents an innovative approach for personalized treatments and its applications are being explored in various anatomical sites to fully understand potential advantages. This study describes the first clinical experience of MRgRT application patients with locally advanced cervical cancer (LACC) undergoing neoadjuvant chemoradiotherapy. The feasibility technique is evaluated toxicity profile outcomes reported.Patients LACC (International...
Background: Artificial Intelligence (AI) is increasingly used for process management in daily life. In the medical field AI becoming part of computerized systems to manage information and encourage generation evidence. Here we present development application IT hospital, creation a DataMart clinical research processes breast cancer. Materials methods: A multidisciplinary team radiation oncologists, epidemiologists, surgeons, data scientists, experts worked together identify relevant sources...
Sentinel lymph node biopsy (SLNB) following neoadjuvant treatment (NACT) has been questioned by many studies that reported heterogeneous identification (IR) and false negative rates (FNR). As a result, some patients receive axillary dissection (ALND) regardless of response to NACT, leading potential overtreatment. To better assess reliability clinical significance SLNB status on ycN0 patients, we retrospectively analyzed oncological outcomes 399 treated between January 2016 December 2019...
Oncoplastic surgery level II techniques (OPSII) are used in patients with operable breast cancer. There is no evidence regarding their safety and efficacy after neoadjuvant chemotherapy (NAC). The aim of this study was to compare the oncological aesthetic outcomes technique compared those observed mastectomy immediate reconstruction (MIBR), post-NAC undergoing between January 2016 March 2021. Local disease-free survival (L-DFS), regional (R-DFS), distant (D-DFS), overall (OS) were compared;...